Quantum Genomics, an innovative biopharmaceutical company developing new therapies for cardiovascular diseases (Alternext – FR0011648971 – ALQGC), announces the appointment of Marc Karako and Jean-Philippe Milon, respectively CFO and COO. They will strengthen the management team of Quantum Genomics, supporting Lionel Ségard, Chairman and CEO, and Fabrice Balavoine, Vice President Research & Development.
[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2014/05/QGC_PR_NOMINATIONS_20140514_UK.pdf” target=”_blank” title=”Download the pdf” size=”small” color=”red”]
